相关实验视频

Updated: Mar 1, 2026

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

达达增强CD8⁺ T细胞干细胞以提高抗瘤免疫力和免疫疗法的有效性

Mingyue Bi^1,2, Fei Li², Heng Jiang³

¹Department of Clinical Laboratory, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

|February 27, 2026

概括

双胺二乙酸 (DADA) 通过促进原始物耗尽的CD8+ T (Tpex) 细胞的积累,增强抗瘤免疫力. 达达通过代谢重编程增强了Tpex细胞干性,提高了免疫治疗的疗效.

科学领域:

免疫学免疫学免疫学
代谢途径代谢途径
癌症免疫疗法癌症免疫疗法

背景情况:

原始体耗尽的CD8+ T (Tpex) 细胞是长期抗瘤免疫和免疫治疗反应至关重要的干细胞类子集.
提高Tpex细胞功能是改善癌症治疗结果的关键策略.

研究的目的:

调查二醇胺二乙酸盐 (DADA) 在调节CD8+T细胞抗瘤免疫力中的作用.
为了确定DADA对Tpex细胞积累和瘤微环境中的干细胞的影响.
探索DADA的潜力,以提高现有免疫疗法的疗效.

主要方法:

用DADA治疗小鼠模型,以评估其对CD8+T细胞介导的抗瘤免疫力的影响.
机理学研究涉及分析DADA.通过DADA.抑制pyruvate脱酶激酶的抑制.
在体外实验中评估了DADA对仿真抗原受体 (CAR) -T细胞扩张和干细胞的作用.

主要成果:

达达治疗促进了Tpex细胞在瘤微环境中的积累.
达达通过增加氧化化 (OXPHOS) 和线粒体适应性通过酸盐脱酶激酶抑制增强了CD8+T细胞干性.
在小鼠中,DADA治疗改善了PD-1阻断疗法的疗效,并在体外增强了CAR-T细胞的抗瘤疗效.

结论:

通过代谢重编程,DADA有效地增强了CD8+ T细胞干细胞的活性,特别是通过向pyruvate转化为Acetyl-CoA.
达达代表了一种有前途的治疗剂,可以增强抗瘤免疫力,并提高癌症免疫疗法的有效性.
像DADA这样的代谢干预提供了一种新的方法来增强基于T细胞的癌症治疗.

关键词:

在 CD8+ T 细胞中.抗瘤免疫力抗瘤免疫力代谢重编程是指代谢重编程.树干性树干性

更多相关视频

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

T Cell Activation and Clonal Selection

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...